PROLOR Biotech To Present at the BIO-Europe Spring 2010 Conference

NES-ZIONA, Israel, March 5 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today announced that PROLOR's management will give a corporate presentation at the BIO-Europe Spring 2010 Conference to be held at the Centre Convencions Internacional Barcelona in Barcelona, Spain, on March 9, 2010 at 2:45pm local time.

For more information on the conference, visit http://www.ebdgroup.com/bes/.

ABOUT PROLOR BIOTECH

PROLOR Biotech, Inc. is a biopharmaceutical company applying unique technologies, including its patented CTP technology, primarily to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales.  The CTP technology is applicable to virtually all proteins and PROLOR is currently developing long-acting versions of human growth hormone, which is in clinical development, and interferon beta, factor VII and erythropoietin, which are in preclinical development, as well as an anti-obesity peptide.  For more information on PROLOR, visit http://www.prolor-biotech.com.

SOURCE PROLOR Biotech, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED